Hyperaldosteronism: Clinical Trials

6 trials for Hyperaldosteronism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 6

Follow Hyperaldosteronism: new trials by email Literature Review of Hyperaldosteronism trials Research Report on Hyperaldosteronism

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Finerenone for Patients With Primary Aldosteronism (FAIRY)
Finerenone Oral Tablet, Spironolactone Oral Tablet - Primary Aldosteronism
Phase 4CompletedChongqing Medical University3062024-06-042026-09-25
The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism
Finerenone - Primary Aldosteronism, Finerenone
Phase 4CompletedThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School552024-03-012025-09-10
Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism
finerenone - Primary Aldosteronism
Phase 4CompletedChongqing Medical University602023-06-212024-06-18
MR Antagonist and LSD1
Eplerenone, Amlodipine - Hypertension, Mineralocorticoid Excess
Phase 4CompletedBrigham and Women's Hospital3002022-02-032026-10-01
Randomized Clinical Trial of Posterior Retroperitoneoscopic Adrenalectomy Versus Lateral Laparoscopic Adrenalectomy
Posterior RA, Lateral transperitoneal LA - Adrenal Tumor, Pheochromocytoma
Phase 4CompletedJagiellonian University652006-01-012013-10-10
Kallikrein-kinin (KKS) and Renin-angiotensin-aldosterone System (RAAS) in Primary Aldosteronism
captopril, Losartan (drug) - Hyperaldosteronism
Phase 4CompletedNational Taiwan University Hospital1002002-07-012014-12-17

Narrower conditions

Hypertension (2)  ·  Adrenal Gland Neoplasms (1)  ·  Cushing Syndrome (1)  ·  Pheochromocytoma (1)

Broader conditions

Adrenal Gland Diseases (6)  ·  Adrenocortical Hyperfunction (6)  ·  Endocrine System Diseases (6)  ·  Cardiovascular Diseases (2)  ·  Vascular Diseases (2)  ·  Endocrine Gland Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neuroectodermal Tumors (1)  ·  Neuroendocrine Tumors (1)  ·  Paraganglioma (1)

Interventions

finerenone (3)  ·  Amlodipine (1)  ·  Captopril (1)  ·  Eplerenone (1)  ·  Losartan (1)  ·  Nifedipine (1)  ·  Pharmaceutical Preparations (1)  ·  Spironolactone (1)

Sponsors

Chongqing Medical University (2)  ·  Brigham and Women's Hospital (1)  ·  Jagiellonian University (1)  ·  National Taiwan University Hospital (1)  ·  The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)

Countries

China (3)  ·  Poland (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Andrea Haas, MD (1)  ·  Kwan-Dun Wu, Md, PhD (1)  ·  Ping Li (1)  ·  Qifu Q Li, PhD (1)  ·  Shumin Yang (1)  ·  Vin-Cent Wu, MD (1)

Results publications

PMID 25243546, PMID 41568520